ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1245

Evaluating a Diagnostic Algorithm for Childhood Sjögren’s Disease

Sara Stern1, Matthew Basiaga2, Linda Amoafo1, Seunghee Cha3, Akaluck Thatayatikom4, Erin Treemarcki1, Rachel Randell5, Brian Dizon6, Jamie Diianni7, Sharon Tiger8, Janet Orrock9, Simone Appenzeller10, Cuoghi Edens11 and Scott Lieberman12, 1University of Utah School of Medicine, Salt Lake City, UT, 2Mayo Clinic, Rochester, MN, 3Department of Oral & Maxillofacial Diagnostic Sciences, University of Florida College of Dentistry and Center for Orphaned Autoimmune Disorders (COAD), Gainesville, FL, 4AdventHealth for Children, Orlando, FL, Orlando, FL, 5Duke University School of Medicine, Durham, NC, 6National Institute of Arthritis and Musculoskelatal and Skin Diseases, Bethesda, MD, 7Childhood Arthritis and Rheumatology Research Alliance (CARRA), Washington, DC, 8Childhood Arthritis and Rheumatology Research Alliance (CARRA), Beltsville, MD, 9The University of Texas at Austin Dell Medical School, Austin, TX, 10UNICAMP, Campinas, Brazil, 11University of Chicago, Chicago, IL, 12University of Iowa Carver College of Medicine, Iowa City, IA

Meeting: ACR Convergence 2023

Keywords: Pediatric rheumatology, Sjögren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1221–1255) Pediatric Rheumatology – Clinical Poster II: Connective Tissue Disease

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: There are no widely accepted diagnostic or classification criteria for childhood Sjögren’s disease (cSjD). To address the urgent need for consensus, the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Sjogren’s Workgroup created a clinical diagnostic algorithm for cSjD. This study evaluates the sensitivity of the diagnostic algorithm to diagnose cSjD using an international cohort of patients.

Methods: The diagnostic algorithm was developed per expert opinion and has four distinct clinical pathway entry points: Parotitis (P), Systemic/Neurologic Manifestations (SN), Sicca symptoms (SIC) and Incidental Salivary or Lacrimal Gland Inflammation on Imaging (INC). The algorithm classifies patients as cSjD, probable cSjD, and negative for cSjD. The validation cohort was an international cohort of 300 cSjD cases, which includes extensive demographic and clinical information. De-identified clinical data from the cSjD cohort was put through the diagnostic algorithm. A response of Sjögren’s disease (SjD) and probable SjD was classified as “positive” for SjD and all other responses were classified as “negative”. Two analyses for the sensitivity of the algorithm for diagnosis were performed, one putting all patients through all pathways, and the other with patients only being put through the pathway they would meet criteria for entry into.

Results: The cSjD cohort (n=300) is 83% female with a mean age of diagnosis of 12 (9,15) years. Among the 300 cSjD cases, 100 (33%) were positive based on the algorithm across all pathways. 100 patients had adequate data allowing them to complete at least one of the 4 pathways, 75% of whom were positive across all pathways. Within each pathway, sensitivity of the algorithm ranged from 23-43% (all cases, Table 1) and 50-82% (limited to cases with complete data, Table 2). The proportion of patients without information for each variable is as follows: parotid biopsy (98%), ocular or oral screen (91%), minor salivary gland biopsy (65%), salivary gland ultrasound (65%) and positive SSA or SSB (2%).

Conclusion: The sensitivity of the algorithm was limited by the lack of completion of diagnostic studies commonly performed in adults with SjD. The P and SIC arms of the algorithm were the most sensitive arms of the algorithm. The SN arm was the least sensitive arm, possibly due to the inhomogeneous and rare presentations in cSjD. Invasive and difficult testing were the least likely to be completed. This algorithm has adequate sensitivity in the setting of complete data, suggesting it is an appropriate diagnostic algorithm for cSjD until a more sensitive, pediatric specific classification criterion can be developed.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: S. Stern: None; M. Basiaga: None; L. Amoafo: None; S. Cha: None; A. Thatayatikom: None; E. Treemarcki: None; R. Randell: biogen, 11, 12, spousal employment, Merck/MSD, 11; B. Dizon: None; J. Diianni: None; S. Tiger: None; J. Orrock: None; S. Appenzeller: None; C. Edens: None; S. Lieberman: None.

To cite this abstract in AMA style:

Stern S, Basiaga M, Amoafo L, Cha S, Thatayatikom A, Treemarcki E, Randell R, Dizon B, Diianni J, Tiger S, Orrock J, Appenzeller S, Edens C, Lieberman S. Evaluating a Diagnostic Algorithm for Childhood Sjögren’s Disease [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/evaluating-a-diagnostic-algorithm-for-childhood-sjogrens-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaluating-a-diagnostic-algorithm-for-childhood-sjogrens-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology